Lusian Pharmaceuticals Private Limited
About Lusian Pharmaceuticals Private Limited
Data last updated:
Lusian Pharmaceuticals Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U52609UR2017PTC008067. Its GSTIN is 05AADCL3975H1ZE (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Maneesha and Ajay Singh Panwar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dehradun, Uttarakhand.
As per the financials filed for FY 2025, the company reported a revenue of ₹95.53 Lakh, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹42,415 (net margin 0.4%) and EBITDA of ₹4.01 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 14% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lusian Pharmaceuticals Private Limited's registered office is in Dehradun, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKhasra No 549, Vishnu Puram Lane No – 4, Dehradun, Uttarakhand, India – 248008
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Lusian Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lusian Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lusian Pharmaceuticals Private Limited, buy the company report.
Financials of Lusian Pharmaceuticals Private Limited
FY 2025 filings availableLusian Pharmaceuticals Private Limited reported revenue of ₹95.53 Lakh (up 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 40% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹42,415 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lusian Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lusian Pharmaceuticals Private Limited
Lusian Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maneesha | Director | 19 Sep 2017 | 9 Years 1 Months | Current |
| Ajay Singh Panwar | Director | 30 Aug 2017 | 9 Years 2 Months | Current |
Peer comparison
Lusian Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axeltis Healthcare Private Limited | ₹95.71 Lakh (FY 2025) | -3.0% | Indore, Madhya Pradesh, India | |||
| Zealous Pharmaceuticals Private Limited | ₹95.71 Lakh (FY 2025) | 9.0% | Bhopal, Madhya Pradesh, India | |||
| Lusian Pharmaceuticals Private Limitedthis company | ₹95.53 Lakh (FY 2025) | ₹42,415 | 0.4% | 40.0% | Dehradun, Uttarakhand, India | |
| RGV Healthcare Private Limited | ₹95.33 Lakh (FY 2025) | 41.0% | Lucknow, Uttar Pradesh, India | |||
| Guthy-Renker Marketing Private Limited | ₹95.31 Lakh (FY 2017) | -58.0% | New Delhi, Delhi, India | |||
| Stroff Pharmaceutical Private Limited | ₹95.3 Lakh (FY 2025) | 29.0% | Lucknow, Uttar Pradesh, India | |||
| Poalmi Pharmaceuticals Private Limited | ₹95.13 Lakh (FY 2025) | 3.0% | Patna, Bihar, India |
To see the full peer comparison of Lusian Pharmaceuticals Private Limited, buy the company report.
Auditor
Lusian Pharmaceuticals Private Limited is audited by SANJAY MISRA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY MISRA & CO | FY 2018 | 005122C |
Shareholding
The shareholding of Lusian Pharmaceuticals Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Lusian Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Nov 2018 | 100218962 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Lusian Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lusian Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lusian Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AADCL3975H1ZE | Uttarakhand | Active | 01 Nov 2017 |
To see the full GST registrations and return filing status of Lusian Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lusian Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Arvind Nautiyal ceased to be Director on 20 Sep 2017.
Frequently asked questions
Lusian Pharmaceuticals is an active private limited company based in Dehradun, Uttarakhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 August 2017 (9+ years old) and is registered under CIN U52609UR2017PTC008067.
Lusian Pharmaceuticals has 2 current directors:
- Maneesha - Director
- Ajay Singh Panwar - Director
The latest financial statements of Lusian Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Lusian Pharmaceuticals is 05AADCL3975H1ZE, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Lusian Pharmaceuticals is U52609UR2017PTC008067. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lusian Pharmaceuticals was incorporated on 30 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Lusian Pharmaceuticals by revenue are Axeltis Healthcare Private Limited, Zealous Pharmaceuticals Private Limited, RGV Healthcare Private Limited, Guthy-Renker Marketing Private Limited, Stroff Pharmaceutical Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Arvind Nautiyal ceased to be Director on 20 Sep 2017. Arvind Negi ceased to be Director on 20 Sep 2017. Maneesha was appointed as Director on 19 Sep 2017. Lusian Pharmaceuticals has 4 board changes on record in total.
The registered office of Lusian Pharmaceuticals is at Khasra No 549, Vishnu Puram Lane No – 4, Dehradun, Uttarakhand, India – 248008.
Lusian Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Lusian Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
